ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.45 Billion SEK | 95.72% |
| 2022 | 744.31 Million SEK | 41.73% |
| 2021 | 525.14 Million SEK | 268.67% |
| 2020 | 142.44 Million SEK | -1.3% |
| 2019 | 144.31 Million SEK | 5.32% |
| 2018 | 137.02 Million SEK | 17.87% |
| 2017 | 116.24 Million SEK | 23.05% |
| 2016 | 94.46 Million SEK | 12.06% |
| 2015 | 84.3 Million SEK | 16.85% |
| 2014 | 72.14 Million SEK | 111.08% |
| 2013 | 34.17 Million SEK | 45.9% |
| 2012 | 23.42 Million SEK | 3696.6% |
| 2011 | 617 Thousand SEK | -23.35% |
| 2010 | 805 Thousand SEK | 0.0% |
| 2008 | - SEK | 0.0% |
| 2007 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.46 Billion SEK | 0.29% |
| 2024 Q3 | 1.64 Billion SEK | -1.64% |
| 2024 Q2 | 1.66 Billion SEK | 14.22% |
| 2023 Q2 | 1.09 Billion SEK | 56.54% |
| 2023 Q1 | 699.3 Million SEK | -6.05% |
| 2023 Q3 | 1.09 Billion SEK | -0.16% |
| 2023 FY | 1.45 Billion SEK | 95.72% |
| 2023 Q4 | 1.45 Billion SEK | 33.28% |
| 2022 Q4 | 744.31 Million SEK | 40.31% |
| 2022 FY | 744.31 Million SEK | 41.73% |
| 2022 Q1 | 525.75 Million SEK | 0.12% |
| 2022 Q2 | 527.51 Million SEK | 0.34% |
| 2022 Q3 | 530.48 Million SEK | 0.56% |
| 2021 Q3 | 272.5 Million SEK | 1.3% |
| 2021 Q4 | 525.14 Million SEK | 92.71% |
| 2021 Q1 | 144.2 Million SEK | 1.23% |
| 2021 Q2 | 269.01 Million SEK | 86.56% |
| 2021 FY | 525.14 Million SEK | 268.67% |
| 2020 Q2 | 144.04 Million SEK | 0.05% |
| 2020 Q4 | 142.44 Million SEK | -0.12% |
| 2020 Q3 | 142.61 Million SEK | -1.0% |
| 2020 Q1 | 143.97 Million SEK | -0.23% |
| 2020 FY | 142.44 Million SEK | -1.3% |
| 2019 FY | 144.31 Million SEK | 5.32% |
| 2019 Q4 | 144.31 Million SEK | -7.86% |
| 2019 Q2 | 145.26 Million SEK | 0.18% |
| 2019 Q1 | 145 Million SEK | 5.82% |
| 2019 Q3 | 156.62 Million SEK | 7.82% |
| 2018 FY | 137.02 Million SEK | 17.87% |
| 2018 Q4 | 137.02 Million SEK | -9.18% |
| 2018 Q3 | 150.88 Million SEK | 14.25% |
| 2018 Q2 | 132.06 Million SEK | 13.5% |
| 2018 Q1 | 116.34 Million SEK | 0.09% |
| 2017 Q4 | 116.24 Million SEK | 491.29% |
| 2017 Q3 | 19.66 Million SEK | -79.54% |
| 2017 Q2 | 96.07 Million SEK | -0.51% |
| 2017 Q1 | 96.56 Million SEK | 2.22% |
| 2017 FY | 116.24 Million SEK | 23.05% |
| 2016 Q4 | 94.46 Million SEK | -1.79% |
| 2016 Q3 | 96.18 Million SEK | 1.71% |
| 2016 Q2 | 94.57 Million SEK | -1.16% |
| 2016 Q1 | 95.68 Million SEK | 13.5% |
| 2016 FY | 94.46 Million SEK | 12.06% |
| 2015 Q1 | 72.61 Million SEK | 0.66% |
| 2015 Q2 | 89.15 Million SEK | 22.77% |
| 2015 Q4 | 84.3 Million SEK | -1.7% |
| 2015 Q3 | 85.76 Million SEK | -3.8% |
| 2015 FY | 84.3 Million SEK | 16.85% |
| 2014 FY | 72.14 Million SEK | 111.08% |
| 2014 Q4 | 72.14 Million SEK | 572.4% |
| 2014 Q3 | 10.72 Million SEK | -74.94% |
| 2014 Q2 | 42.81 Million SEK | -1.05% |
| 2014 Q1 | 43.26 Million SEK | 26.6% |
| 2013 Q3 | 42.72 Million SEK | 282.65% |
| 2013 Q4 | 34.17 Million SEK | -20.01% |
| 2013 FY | 34.17 Million SEK | 45.9% |
| 2013 Q1 | 20 Million SEK | -14.62% |
| 2013 Q2 | 11.16 Million SEK | -44.17% |
| 2012 Q3 | 25.76 Million SEK | 3.64% |
| 2012 FY | 23.42 Million SEK | 3696.6% |
| 2012 Q1 | 14.43 Million SEK | 2238.74% |
| 2012 Q4 | 23.42 Million SEK | -9.08% |
| 2012 Q2 | 24.85 Million SEK | 72.26% |
| 2011 Q4 | 617 Thousand SEK | -80.5% |
| 2011 FY | 617 Thousand SEK | -23.35% |
| 2011 Q2 | 3.65 Million SEK | 12.22% |
| 2011 Q1 | 3.25 Million SEK | 304.72% |
| 2011 Q3 | 3.16 Million SEK | -13.46% |
| 2010 Q2 | - SEK | 0.0% |
| 2010 FY | 805 Thousand SEK | 0.0% |
| 2010 Q1 | - SEK | 0.0% |
| 2010 Q4 | 805 Thousand SEK | 0.0% |
| 2010 Q3 | - SEK | 0.0% |
| 2009 Q1 | - SEK | 0.0% |
| 2009 Q2 | - SEK | 0.0% |
| 2008 FY | - SEK | 0.0% |
| 2008 Q4 | - SEK | 0.0% |
| 2008 Q1 | - SEK | 0.0% |
| 2007 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 0.0% |
| Arcoma AB | 1.92 Million SEK | -75499.377% |
| Bactiguard Holding AB (publ) | 42.3 Million SEK | -3343.483% |
| BICO Group AB (publ) | 1.75 Billion SEK | 17.01% |
| Boule Diagnostics AB (publ) | 57.7 Million SEK | -2424.783% |
| CellaVision AB (publ) | 28.66 Million SEK | -4982.333% |
| Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -653173.543% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.75 Million SEK | -83003.252% |
| Duearity AB (publ) | 2.94 Million SEK | -49451.02% |
| Dignitana AB (publ) | 6.07 Million SEK | -23872.355% |
| Episurf Medical AB (publ) | 2.3 Million SEK | -63239.13% |
| Getinge AB (publ) | 3.9 Billion SEK | 62.675% |
| Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | -22831.188% |
| Iconovo AB (publ) | 4.9 Million SEK | -29588.818% |
| Integrum AB (publ) | 4.84 Million SEK | -29970.892% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -707002.085% |
| Mentice AB (publ) | 2.14 Million SEK | -67847.761% |
| OssDsign AB (publ) | 214 Thousand SEK | -680647.664% |
| Paxman AB (publ) | 2.53 Million SEK | -57435.545% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 3 Million SEK | -48395.34% |
| SciBase Holding AB (publ) | 4.17 Million SEK | -34760.014% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 19.2 Million SEK | -7485.92% |
| Sedana Medical AB (publ) | 1.01 Million SEK | -143852.569% |
| Senzime AB (publ) | 8.57 Million SEK | -16882.98% |
| SpectraCure AB (publ) | 4.39 Million SEK | -33031.681% |
| Stille AB | 38.06 Million SEK | -3727.037% |
| Vitrolife AB (publ) | 1.87 Billion SEK | 22.304% |
| Xvivo Perfusion AB (publ) | 21.16 Million SEK | -6781.761% |